Micah Girard
Optometrist · Cocoa, FLNPI 1285749911
Payments from drug & device makers
Across 23 payments — averaging $107.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Glaukos Corporation$152
- Johnson & Johnson Vision Care, Inc.$129
- Optos, Inc.$110
- Novartis$98
- Visionix USA, Inc$91
- plus $310 from 6 others
What the payments were for
- Travel & lodging$1,10745%
- Food & beverage$1,21149%
- Education$361%
- Entertainment$1104%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 8 | $1,575 |
| Glaukos Corporation | 1 | $152 |
| Johnson & Johnson Vision Care, Inc. | 1 | $129 |
| Optos, Inc. | 1 | $110 |
| Novartis | 1 | $98 |
| Visionix USA, Inc | 1 | $91 |
| Coopervision Inc. | 2 | $78 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $75 |
| Optovue, Inc. | 1 | $59 |
| Oyster Point Pharma, Inc. | 1 | $48 |
| Bausch & Lomb Americas Inc. | 2 | $36 |
| Lombart Brothers, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,464 in reported general payments places this provider in the 75th percentile of 3,166 optometrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 24 | $16,826 |
| Latanoprost | 208 | $2,962 |
| Brimonidine Tartrate | 24 | $1,679 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 52 | $1,143 |
| Timolol Maleate | 79 | $809 |
| Dorzolamide Hcl | 13 | $244 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 13 | $202 |
| ErythromycinErythromycin Base | 17 | $182 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Cocoa
- Michael KynnJacksonville$4.5M
- Christine HalodaJacksonville$3.1M
- Bradley GieddWinter Park$2.5M
- Christopher PearsonLongwood$2.5M
- Mark PerryOrlando$1.6M
- Bryan StamJacksonville Beach$1M
- Oksana SovaJacksonville$841K
- James HoffmanOrange Park$795K
- April JasperWest Palm Beach$781K
- Jerry RobbenSt Augustine$663K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.